sales@fnfresearch.comTel: +86 21 80360450 | USA: +1-347-989-3985

Search Market Research Report

Home / Healthcare / Global Dental Anticoagulants

Global Dental Anticoagulants Market By Drug Class (DOACs, Vitamin K Antagonist, Heparin, and Others), By Route of Administration (Oral Anticoagulants and Injectable Anticoagulants), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Regions: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026

  • Publish On: Feb-2020
  • Total Pages: 110
  • Report Code: FAF-383
  • Base Year: 2019
  • Format:

Industry Insights

The use of trusted tools by our analyst has helped them conclude the market size of the global Dental Anticoagulants market in terms of USD Million during the forecast timeframe. The report showcases the historic data from 2016 to 2019 along with the forecast data from 2020 to 2026. The market research study provides the market statistics and drivers that help the market expand in a graphical and theoretical pattern.

Our experts have used some of the best tools like Porter’s Five Forces, PESTEL analysis, and SWOT analysis to study market trends and challenges. These tools also help study each and every microscopic data that has an impact on market growth. The market-oriented study offers all the details such as mergers, joint ventures, market share, market statistics, emerging trends, challenges & opportunities, and new launches.

Anticoagulant drugs are commonly referred to as blood thinners. These are chemical substances that help prevent or lower coagulation of blood and instead increase blood clotting time. Anticoagulant drugs are primarily used in case of chronic medical conditions with a higher risk of blood clots. Anticoagulant drugs such as the direct anticoagulants are generally used during dental invasive treatments and surgeries.

The growing occurrence of severe disorders such as diabetes, cardiovascular diseases, cancer, etc. along with technological innovations is likely to surge the Dental Anticoagulants market. In addition, the increasing expenditure on research and development will further supplement the growth of the market. The rising number of the older population, high labor costs, and high supply & demand will further propel the market during the forecast timeframe. Likewise, growing healthcare awareness and disposable income are anticipated to drive the market growth.

Direct oral anticoagulants (DOACs) are widely used anticoagulants due to their easy use and excellent safety profile. They have set doses and do not require regular international standardizations.  Thus, the high demand for DOACs owing to their safety is expected to drive the global Dental Anticoagulants market over the forecast period. The novel alternative anticoagulants are expected to open new doors of opportunities for the Dental Anticoagulants market. However, the risks associated with the use of anticoagulant and stringent regulatory requirements are the major market restraints.

Based on drug class, the market for dental anticoagulants is segregated into DOACs, Vitamin K Antagonist, Heparin, and Others. On the basis of route of administration, the global Dental Anticoagulants market is divided into Oral Anticoagulants and Injectable Anticoagulants. In terms of distribution channel, the market is categorized into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.

Some of the key players in the global Dental Anticoagulants market are Daiichi Sankyo Company, Limited, Sanofi S.A, Aspen Holdings, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Boehringer Ingelheim GmbH, Pfizer, Inc., Abbott, Portola Pharmaceuticals, Inc., and Mylan N.V.

The global Dental Anticoagulants market is segmented into:

Global Dental Anticoagulants Market: By Drug Class

  • DOACs (Direct Oral Anticoagulants)
    • Apixaban
    • Dabigatran
    • Rivaroxaban
    • Edoxaban
    • Others
  • Vitamin K Antagonist
  • Heparin
  • Others

Global Dental Anticoagulants Market: By Route of Administration

  • Oral Dental Anticoagulants
  • Injectable Dental Anticoagulants

Global Dental Anticoagulants Market: By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Dental Anticoagulants Market: By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-East Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • The Middle-East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle-East Africa

Key Pointers Addressed by the Report

  • Historical data and forecast analysis of the market
  • Drivers and Restraints affecting market dynamics
  • Exhaustive analysis about the future market trends
  • Comprehensive information about the leading market segments and region
  • Strategic developments made by the competitive players and in-depth analysis of its impact on market growth.

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. Dental Anticoagulants market – Drug Class Analysis
    1. 2.1. Global Dental Anticoagulants Market – Drug Class Overview
    2. 2.2. Global Dental Anticoagulants Market Share, by Drug Class, 2018 & 2025 (USD Million)
    3. 2.3. DOACs
      1. 2.3.1. Global DOACs Dental Anticoagulants Market, 2016-2026 (USD Million)
    4. 2.4. Vitamin K Antagonist
      1. 2.4.1. Global Vitamin K Antagonist Dental Anticoagulants Market, 2016-2026 (USD Million)
    5. 2.5. Heparin
      1. 2.5.1. Global Heparin Dental Anticoagulants Market, 2016-2026 (USD Million)
    6. 2.6. Others
      1. 2.6.1. Global Others Dental Anticoagulants Market, 2016-2026 (USD Million)
  3. CHAPTER 3. Dental Anticoagulants market – Route of Administration Analysis
    1. 3.1. Global Dental Anticoagulants Market – Route of Administration Overview
    2. 3.2. Global Dental Anticoagulants Market Share, by Route of Administration, 2018 & 2025 (USD Million)
    3. 3.3. Oral Anticoagulants
      1. 3.3.1. Global Oral Anticoagulants Dental Anticoagulants Market, 2016-2026 (USD Million)
    4. 3.4. Injectable Anticoagulants
      1. 3.4.1. Global Injectable Anticoagulants Dental Anticoagulants Market, 2016-2026 (USD Million)
  4. CHAPTER 4. Dental Anticoagulants market – Distribution Channel Analysis
    1. 4.1. Global Dental Anticoagulants Market – Distribution Channel Overview
    2. 4.2. Global Dental Anticoagulants Market Share, by Distribution Channel, 2018 & 2025 (USD Million)
    3. 4.3. Hospital Pharmacies
      1. 4.3.1. Global Hospital Pharmacies Dental Anticoagulants Market, 2016-2026 (USD Million)
    4. 4.4. Retail Pharmacies
      1. 4.4.1. Global Retail Pharmacies Dental Anticoagulants Market, 2016-2026 (USD Million)
    5. 4.5. Online Pharmacies
      1. 4.5.1. Global Online Pharmacies Dental Anticoagulants Market, 2016-2026 (USD Million)
  5. CHAPTER 5. Dental Anticoagulants market – Regional Analysis
    1. 5.1. Global Dental Anticoagulants Market Regional Overview
    2. 5.2. Global Dental Anticoagulants Market Share, by Region, 2018 & 2025 (Value)
    3. 5.3. North America
      1. 5.3.1. North America Dental Anticoagulants Market size and forecast, 2016-2026
      2. 5.3.2. North America Dental Anticoagulants Market, by Country, 2018 & 2025 (USD Million)
      3. 5.3.3. North America Dental Anticoagulants Market, by Drug Class, 2016-2026
      4. 5.3.4. North America Dental Anticoagulants Market, by Route of Administration, 2016-2026
      5. 5.3.5. North America Dental Anticoagulants Market, by Distribution Channel, 2016-2026
      6. 5.3.6. U.S.
      7. 5.3.7. Canada
    4. 5.4. Europe
      1. 5.4.1. Europe Dental Anticoagulants Market size and forecast, 2016-2026
      2. 5.4.2. Europe Dental Anticoagulants Market, by Country, 2018 & 2025 (USD Million)
      3. 5.4.3. Europe Dental Anticoagulants Market, by Drug Class, 2016-2026
      4. 5.4.4. Europe Dental Anticoagulants Market, by Route of Administration, 2016-2026
      5. 5.4.5. Europe Dental Anticoagulants Market, by Distribution Channel, 2016-2026
      6. 5.4.6. Germany
      7. 5.4.7. France
      8. 5.4.8. U.K.
      9. 5.4.9. Italy
      10. 5.4.10. Spain
      11. 5.4.11. Rest of Europe
    5. 5.5. Asia Pacific
      1. 5.5.1. Asia Pacific Dental Anticoagulants Market size and forecast, 2016-2026
      2. 5.5.2. Asia Pacific Dental Anticoagulants Market, by Country, 2018 & 2025 (USD Million)
      3. 5.5.3. Asia Pacific Dental Anticoagulants Market, by Drug Class, 2016-2026
      4. 5.5.4. Asia Pacific Dental Anticoagulants Market, by Route of Administration, 2016-2026
      5. 5.5.5. Asia Pacific Dental Anticoagulants Market, by Distribution Channel, 2016-2026
      6. 5.5.6. China
      7. 5.5.7. Japan
      8. 5.5.8. India
      9. 5.5.9. South Korea
      10. 5.5.10. South-East Asia
      11. 5.5.11. Rest of Asia Pacific
    6. 5.6. Latin America
      1. 5.6.1. Latin America Dental Anticoagulants Market size and forecast, 2016-2026
      2. 5.6.2. Latin America Dental Anticoagulants Market, by Country, 2018 & 2025 (USD Million)
      3. 5.6.3. Latin America Dental Anticoagulants Market, by Drug Class, 2016-2026
      4. 5.6.4. Latin America Dental Anticoagulants Market, by Route of Administration, 2016-2026
      5. 5.6.5. Latin America Dental Anticoagulants Market, by Distribution Channel, 2016-2026
      6. 5.6.6. Brazil
      7. 5.6.7. Mexico
      8. 5.6.8. Rest of Latin America
    7. 5.7. The Middle-East and Africa
      1. 5.7.1. The Middle-East and Africa Dental Anticoagulants Market size and forecast, 2016-2026
      2. 5.7.2. The Middle-East and Africa Dental Anticoagulants Market, by Country, 2018 & 2025 (USD Million)
      3. 5.7.3. The Middle-East and Africa Dental Anticoagulants Market, by Drug Class, 2016-2026
      4. 5.7.4. The Middle-East and Africa Dental Anticoagulants Market, by Route of Administration, 2016-2026
      5. 5.7.5. The Middle-East and Africa Dental Anticoagulants Market, by Distribution Channel, 2016-2026
      6. 5.7.6. GCC Countries
      7. 5.7.7. South Africa
      8. 5.7.8. Rest of Middle-East Africa
  6. CHAPTER 6. Dental Anticoagulants market – Competitive Landscape
    1. 6.1. Competitor Market Share – Revenue
    2. 6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 6.3. Strategic Development
      1. 6.3.1. Acquisitions and Mergers
      2. 6.3.2. New Products
      3. 6.3.3. Research & Development Activities
  7. CHAPTER 7. Company Profiles
    1. 7.1. Daiichi Sankyo Company Limited
      1. 7.1.1. Company Overview
      2. 7.1.2. Daiichi Sankyo Company Limited Revenue and Gross Margin
      3. 7.1.3. Product portfolio
      4. 7.1.4. Recent initiatives
    2. 7.2. Sanofi S.A
      1. 7.2.1. Company Overview
      2. 7.2.2. Sanofi S.A Revenue and Gross Margin
      3. 7.2.3. Product portfolio
      4. 7.2.4. Recent initiatives
    3. 7.3. Aspen Holdings
      1. 7.3.1. Company Overview
      2. 7.3.2. Aspen Holdings Revenue and Gross Margin
      3. 7.3.3. Product portfolio
      4. 7.3.4. Recent initiatives
    4. 7.4. Bayer AG
      1. 7.4.1. Company Overview
      2. 7.4.2. Bayer AG Revenue and Gross Margin
      3. 7.4.3. Product portfolio
      4. 7.4.4. Recent initiatives
    5. 7.5. Bristol-Myers Squibb Company
      1. 7.5.1. Company Overview
      2. 7.5.2. Bristol-Myers Squibb Company Revenue and Gross Margin
      3. 7.5.3. Product portfolio
      4. 7.5.4. Recent initiatives
    6. 7.6. GlaxoSmithKline Plc
      1. 7.6.1. Company Overview
      2. 7.6.2. GlaxoSmithKline Plc Revenue and Gross Margin
      3. 7.6.3. Product portfolio
      4. 7.6.4. Recent initiatives
    7. 7.7. Boehringer Ingelheim GmbH
      1. 7.7.1. Company Overview
      2. 7.7.2. Boehringer Ingelheim GmbH Revenue and Gross Margin
      3. 7.7.3. Product portfolio
      4. 7.7.4. Recent initiatives
    8. 7.8. Pfizer Inc.
      1. 7.8.1. Company Overview
      2. 7.8.2. Pfizer Inc. Revenue and Gross Margin
      3. 7.8.3. Product portfolio
      4. 7.8.4. Recent initiatives
    9. 7.9. Abbott
      1. 7.9.1. Company Overview
      2. 7.9.2. Abbott Revenue and Gross Margin
      3. 7.9.3. Product portfolio
      4. 7.9.4. Recent initiatives
    10. 7.10. Portola Pharmaceuticals Inc.
      1. 7.10.1. Company Overview
      2. 7.10.2. Portola Pharmaceuticals Inc. Revenue and Gross Margin
      3. 7.10.3. Product portfolio
      4. 7.10.4. Recent initiatives
    11. 7.11. Mylan N.V.
      1. 7.11.1. Company Overview
      2. 7.11.2. Mylan N.V. Revenue and Gross Margin
      3. 7.11.3. Product portfolio
      4. 7.11.4. Recent initiatives
  8. CHAPTER 8. Dental Anticoagulants — Industry Analysis
    1. 8.1. Dental Anticoagulants Market – Key Trends
      1. 8.1.1. Market Drivers
      2. 8.1.2. Market Restraints
      3. 8.1.3. Market Opportunities
    2. 8.2. Value Chain Analysis
    3. 8.3. Technology Roadmap and Timeline
    4. 8.4. Dental Anticoagulants Market – Attractiveness Analysis
      1. 8.4.1. By Drug Class
      2. 8.4.2. By Route of Administration
      3. 8.4.3. By Distribution Channel
      4. 8.4.4. By Region
  9. CHAPTER 9. Marketing Strategy Analysis, Distributors
    1. 9.1. Marketing Channel
    2. 9.2. Direct Marketing
    3. 9.3. Indirect Marketing
    4. 9.4. Marketing Channel Development Trend
    5. 9.5. Economic/Political Environmental Change
  10. CHAPTER 10. Report Conclusion
  11. CHAPTER 11. Research Approach & Methodology
    1. 11.1. Report Description
    2. 11.2. Research Scope
    3. 11.3. Research Methodology
      1. 11.3.1. Secondary Research
      2. 11.3.2. Primary Research
      3. 11.3.3. Models

      List of Figures

      FIG. 1    Global Dental Anticoagulants Market, 2016-2026 (USD Million)
      FIG. 2    Global Dental Anticoagulants Market Share, by Drug Class, 2018 & 2025 (USD Million)
      FIG. 3    Global DOACs Dental Anticoagulants Market, 2016-2026 (USD Million)
      FIG. 4    Global Vitamin K Antagonist Dental Anticoagulants Market, 2016-2026 (USD Million)
      FIG. 5    Global Heparin Dental Anticoagulants Market, 2016-2026 (USD Million)
      FIG. 6    Global Others Dental Anticoagulants Market, 2016-2026 (USD Million)
      FIG. 7    Global Dental Anticoagulants Market Share, by Route of Administration, 2018 & 2025 (USD Million)
      FIG. 8    Global Oral Anticoagulants Dental Anticoagulants Market, 2016-2026 (USD Million)
      FIG. 9    Global Injectable Anticoagulants Dental Anticoagulants Market, 2016-2026 (USD Million)
      FIG. 10    Global Dental Anticoagulants Market Share, by Distribution Channel, 2018 & 2025 (USD Million)
      FIG. 11    Global Hospital Pharmacies Dental Anticoagulants Market, 2016-2026 (USD Million)
      FIG. 12    Global Retail Pharmacies Dental Anticoagulants Market, 2016-2026 (USD Million)
      FIG. 13    Global Online Pharmacies Dental Anticoagulants Market, 2016-2026 (USD Million)
      FIG. 14    Global Dental Anticoagulants Market Share, by Region, 2018 & 2025
      FIG. 15    North America Dental Anticoagulants Market, 2016-2026
      FIG. 16    U.S. Dental Anticoagulants Market, 2016-2026
      FIG. 17    Canada Dental Anticoagulants Market, 2016-2026
      FIG. 18    Europe Dental Anticoagulants Market, 2016-2026
      FIG. 19    Germany Dental Anticoagulants Market, 2016-2026
      FIG. 20    France Dental Anticoagulants Market, 2016-2026
      FIG. 21    U.K. Dental Anticoagulants Market, 2016-2026
      FIG. 22    Italy Dental Anticoagulants Market, 2016-2026
      FIG. 23    Spain Dental Anticoagulants Market, 2016-2026
      FIG. 24    Rest of Europe Dental Anticoagulants Market, 2016-2026
      FIG. 25    Asia Pacific Dental Anticoagulants Market, 2016-2026
      FIG. 26    China Dental Anticoagulants Market, 2016-2026
      FIG. 27    Japan Dental Anticoagulants Market, 2016-2026
      FIG. 28    India Dental Anticoagulants Market, 2016-2026
      FIG. 29    South  Korea Dental Anticoagulants Market, 2016-2026
      FIG. 30    South-East Asia Dental Anticoagulants Market, 2016-2026
      FIG. 31    Rest of Asia Pacific Dental Anticoagulants Market, 2016-2026
      FIG. 32    Latin America Dental Anticoagulants Market, 2016-2026
      FIG. 33    Brazil Dental Anticoagulants Market, 2016-2026
      FIG. 34    Mexico Dental Anticoagulants Market, 2016-2026
      FIG. 35    Rest of Latin America Dental Anticoagulants Market, 2016-2026
      FIG. 36    The Middle-East and Africa Dental Anticoagulants Market, 2016-2026
      FIG. 37    GCC Countries Dental Anticoagulants Market, 2016-2026
      FIG. 38    South Africa Dental Anticoagulants Market, 2016-2026
      FIG. 39    Rest of Middle-East Africa Dental Anticoagulants Market, 2016-2026
      FIG. 40    Competitor Market Share – Revenue
      FIG. 41    Daiichi Sankyo Company Limited Revenue and Growth Rate
      FIG. 42    Daiichi Sankyo Company Limited Market Share
      FIG. 43    Sanofi S.A Revenue and Growth Rate
      FIG. 44    Sanofi S.A Market Share
      FIG. 45    Aspen Holdings Revenue and Growth Rate
      FIG. 46    Aspen Holdings Market Share
      FIG. 47    Bayer AG Revenue and Growth Rate
      FIG. 48    Bayer AG Market Share
      FIG. 49    Bristol-Myers Squibb Company Revenue and Growth Rate
      FIG. 50    Bristol-Myers Squibb Company Market Share
      FIG. 51    GlaxoSmithKline Plc Revenue and Growth Rate
      FIG. 52    GlaxoSmithKline Plc Market Share
      FIG. 53    Boehringer Ingelheim GmbH Revenue and Growth Rate
      FIG. 54    Boehringer Ingelheim GmbH Market Share
      FIG. 55    Pfizer Inc. Revenue and Growth Rate
      FIG. 56    Pfizer Inc. Market Share
      FIG. 57    Abbott Revenue and Growth Rate
      FIG. 58    Abbott Market Share
      FIG. 59    Portola Pharmaceuticals Inc. Revenue and Growth Rate
      FIG. 60    Portola Pharmaceuticals Inc. Market Share
      FIG. 61    Mylan N.V. Revenue and Growth Rate
      FIG. 62    Mylan N.V. Market Share
      FIG. 63    Market Dynamics
      FIG. 64    Global Dental Anticoagulants – Value Chain Analysis
      FIG. 65    Technology Roadmap and Timeline
      FIG. 66    Market Attractiveness Analysis – By Drug Class
      FIG. 67    Market Attractiveness Analysis – By Route of Administration
      FIG. 68    Market Attractiveness Analysis – By Distribution Channel
      FIG. 69    Market Attractiveness Analysis – By Region
      FIG. 70    Market Channel
      FIG. 71    Marketing Channel Development Trend
      FIG. 72    Growth in World Gross Product, 2008-2018


      List of Tables

      TABLE 1    Global Dental Anticoagulants Market, 2018 & 2025 (USD Million)
      TABLE 2    Global Dental Anticoagulants market, by Drug Class, 2016-2026 (USD Million)
      TABLE 3    Global Dental Anticoagulants market, by Route of Administration, 2016-2026 (USD Million)
      TABLE 4    Global Dental Anticoagulants market, by Distribution Channel, 2016-2026 (USD Million)
      TABLE 5    Global Dental Anticoagulants market, by Region, 2016-2026 (USD Million)
      TABLE 6    North America Dental Anticoagulants Market, by Drug Class, 2016-2026 (USD Million)
      TABLE 7    North America Dental Anticoagulants Market, by Route of Administration, 2016-2026 (USD Million)
      TABLE 8    North America Dental Anticoagulants Market, by Distribution Channel, 2016-2026 (USD Million)
      TABLE 9    Europe Dental Anticoagulants Market, by Drug Class, 2016-2026 (USD Million)
      TABLE 10    Europe Dental Anticoagulants Market, by Route of Administration, 2016-2026 (USD Million)
      TABLE 11    Europe Dental Anticoagulants Market, by Distribution Channel, 2016-2026 (USD Million)
      TABLE 12    Asia Pacific Dental Anticoagulants Market, by Drug Class, 2016-2026 (USD Million)
      TABLE 13    Asia Pacific Dental Anticoagulants Market, by Route of Administration, 2016-2026 (USD Million)
      TABLE 14    Asia Pacific Dental Anticoagulants Market, by Distribution Channel, 2016-2026 (USD Million)
      TABLE 15    Latin America Dental Anticoagulants Market, by Drug Class, 2016-2026 (USD Million)
      TABLE 16    Latin America Dental Anticoagulants Market, by Route of Administration, 2016-2026 (USD Million)
      TABLE 17    Latin America Dental Anticoagulants Market, by Distribution Channel, 2016-2026 (USD Million)
      TABLE 18    The Middle-East and Africa Dental Anticoagulants Market, by Drug Class, 2016-2026 (USD Million)
      TABLE 19    The Middle-East and Africa Dental Anticoagulants Market, by Route of Administration, 2016-2026 (USD Million)
      TABLE 20    The Middle-East and Africa Dental Anticoagulants Market, by Distribution Channel, 2016-2026 (USD Million)
      TABLE 21    Global Dental Anticoagulants Market - Company Revenue Analysis 2016-2019 (USD Million)
      TABLE 22    Global Dental Anticoagulants Market - Company Revenue Share Analysis 2016-2019(%)
      TABLE 23    Acquisitions and Mergers
      TABLE 24    New Product/Service Launch
      TABLE 25    Research & Development Activities
      TABLE 26    Market Drivers
      TABLE 27    Market Restraints
      TABLE 28    Market Opportunities

Key Insights from Primary Research

  • As per our primary respondents, the direct oral anticoagulants (DOACs) are preferred choice of anticoagulants owing to their safety and efficiency profile.
  • As per experts, the worldwide development in the healthcare sector owing to the high prevalence of chronic diseases will propel the market growth.
  • Risk factors such as vascular platelets  along with comorbidities such as renal and or hepatic impairment in individuals has increased during the recent years thus surging the overall demand for anticoagulants.
  • Use of the latest pharmacokinetic or pharmacodynamic properties for the continuous development of anticoagulant medications may offer advantages that may lower the side effects linked with conventional anticoagulant treatments.

Key Recommendations from Analysts

  • As per our analysts, liberty for regular international normalization ratio blood test monitoring along with faster onset & offset action is expected to propel the market growth.
  • Rising development in the research and technological innovations has led to greater adoption and use of dental anticoagulants.
  • The burgeoning market scope for direct oral anticoagulants or novel oral anticoagulants will draw many market players.
  • In 2018, North America showed about 35% market share owing to the leading anticoagulants market in the U.S.
  •  
  • Europe is likely to show significant market growth due to increasing cases of chronic diseases, helpful government policies, and the growing geriatric population in the region.
  • The increasing awareness of the use of oral anticoagulants and disposable income will bolster the global Dental Anticoagulants market.

Market Attractiveness in 2018: By Drug Class

Global Dental Anticoagulants Market

Industry Major Market Players

  • Daiichi Sankyo Company
  • Limited
  • Sanofi S.A
  • Aspen Holdings
  • Bayer AG
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline Plc
  • Boehringer Ingelheim GmbH
  • Pfizer Inc.
  • Abbott
  • Portola Pharmaceuticals
  • Inc.
  • Mylan N.V.

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying
have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2020 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions